2
https://laptopsuggestions.in/fda-accepts-bristol-myers-opdivo-yervoy-app-in-lung-cancer-but-without-a-speedy-review/
Bristol-Myers Squibb’s Opdivo is finally under FDA consideration as a therapy for previously untreated lung cancer, but it will still be a while before it can compete in the key market.Original source: http://www.fiercepharma.com/pharma/fda-accepts-bristol-s-opdivo-yervoy-app-lung-cancer-but-without-a-speedy-review?utm_source=internal&utm_medium=rss